Scientists have been researching whether or not antibodies from COVID-19 patients might help those infected with the virus, ...

Kiniksa (KNSA) shifts from survival to growth as Arcalyst nears blockbuster sales and pipeline KPL-387 readouts loom—get the ...

As biological data volume continues to grow, sequence-based AI is poised to become the dominant discovery layer across pharma ...

Nirsevimab may offer infants stronger protection against severe respiratory syncytial virus than maternal vaccination, ...

The number of ongoing prescription drug shortages rose slightly in the last quarter of 2025, but remained significantly lower ...

An international team, led by Paul R. Fortin of Université Laval, has just identified three markers that would allow for establishing, right at the time of diagnosis, the risk of a lupus ...

Researchers have identified a promising new weapon against triple-negative breast cancer, one of the most aggressive forms of ...

Parents of autistic children are clamoring for a prescription vitamin promoted by federal health officials. But there’s ...

Subclade K (previously known as J.2.4.1) is gaining attention because it appears to be spreading much earlier in the flu ...

Amid a surprisingly severe flu season and a Covid-19 resurgence, those highly contagious respiratory illnesses are drawing ...

If you feel like everyone you know is dealing with a cough, cold and runny nose, it's not in your head. Multiple viruses, not ...

Amid a surprisingly severe flu season and a COVID-19 resurgence, those highly contagious respiratory illnesses are drawing ...